Searching map area
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
? TBD
scientific article published on 07 October 2019
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Instance of
Scholarly article
Subject
Multiple sclerosis
Rituximab
References
Wikidata